If you are researching ETS surgery, you are probably at a point where everything else has failed or has not been enough. Severe palmar hyperhidrosis that affects your ability to use a keyboard, hold a pen, or shake hands without incident is the kind of condition that makes people willing to consider a surgical solution. That is understandable.
ETS is the most effective treatment for focal sweating that exists. It is also one of the most irreversible, and it carries a risk that a significant portion of patients later describe as the worst medical decision they ever made. Both of those things are true, and you need to understand both before going further.
What ETS Surgery Is
Endoscopic thoracic sympathectomy is a minimally invasive surgical procedure performed under general anesthesia. Small incisions are made in the chest wall, and a camera (endoscope) plus surgical instruments are inserted to access the sympathetic nerve chain, which runs alongside the vertebral column inside the chest.
The surgeon either cuts or clamps the sympathetic nerve chain at a specific level (typically T2, T3, or T4, referring to the thoracic vertebral level). The sympathetic nervous system is responsible for the fight-or-flight sweat response. Interrupting the nerve chain at the appropriate level stops the nerve signal from reaching the sweat glands in the targeted area.
Cutting destroys the nerve. The effect is permanent and irreversible.
Clamping uses titanium clips. Theoretically reversible by removing the clips, but reversal success rates are limited and decrease with time as nerve changes become more permanent.
Most current surgeons prefer clamping specifically because it offers some reversal possibility. Some still cut. Ask specifically.
The surgery typically takes 1-2 hours. Hospital stay is usually one night or same-day discharge. Recovery is faster than most people expect for a chest surgery.
Effectiveness
ETS is very effective for the targeted area:
- Palmar hyperhidrosis (hands): Near-complete resolution in the vast majority of patients. This is the best-evidence indication for ETS.
- Axillary hyperhidrosis (armpits): Also very effective, though Botox and MiraDry are usually tried first since they are less invasive.
- Craniofacial hyperhidrosis (face, scalp, blushing): Effective, particularly for blushing. Some surgeons specialize in ETS for this indication.
Results in the targeted area are typically immediate and dramatic. Patients who have spent their entire adult lives with constantly wet hands report that the effect is almost surreal at first.
Compensatory Sweating: The Real Conversation
This is the part of the ETS discussion that cannot be soft-pedaled.
After ETS, the sympathetic nervous system compensates for losing its ability to sweat in the targeted area by increasing sweating elsewhere. This is reflex compensatory sweating. It typically manifests in the trunk (back, chest, abdomen), buttocks, and thighs. It can be mild, moderate, or severe.
Published incidence rates: Studies report compensatory sweating in 30-80% of ETS patients. The wide range reflects differences in how compensation is defined, how it is measured, and which nerve level was treated. Higher treatment levels (T2) tend to produce higher compensatory sweating rates.
The severity question: The more important issue than incidence is severity. A subset of patients develops compensatory sweating that is worse in their daily life than their original hyperhidrosis. Their hands may be dry, but they are now drenched through their shirts at rest. Several studies have found that 10-30% of ETS patients rate their compensatory sweating as severe.
The regret data: ETS has among the highest surgical regret rates of any elective procedure. Multiple surveys of ETS patients find 20-40% reporting they would not have the surgery again, primarily because of compensatory sweating. This is not a rare outlier outcome. It is documented, it is consistent across studies, and any surgeon who does not mention it clearly before operating is not being straight with you.
Patient Community Perspective
Online communities for people with hyperhidrosis are notably divided on ETS. You will find:
- People who say ETS changed their lives and they are grateful
- People who say ETS is the worst decision they ever made and they are fighting for reversal
- Very few neutral responses
This polarization reflects the reality. The procedure works very well for what it targets. The compensatory sweating issue is unpredictable in advance, and when it is severe, it is genuinely debilitating. People who got dry hands but now sweat through three shirts a day describe the trade-off as a significant loss.
The hyperhidrosis patient forums are worth reading before making this decision. Not to be scared off, but to understand the real distribution of outcomes from people who have lived it.
Surgery Levels and Risk-Benefit
The nerve level treated influences both effectiveness and compensatory sweating risk:
T2 (second thoracic ganglion): Targets hand sweating most directly. Highest compensatory sweating risk.
T3: Also addresses hands and armpits. Some evidence suggests slightly lower compensatory risk while maintaining good hand results. Many current surgeons favor T3 over T2 for this reason.
T4: More focused on axillary sweating. Lower compensatory sweating rates, less effective for severe palmar hyperhidrosis.
The field has moved toward lower treatment levels (T3, T4) in an attempt to reduce compensatory sweating risk while maintaining acceptable effectiveness. Ask any surgeon you consult which level they plan to treat and why.
Other Surgical Risks
Beyond compensatory sweating, ETS carries the risks of any surgical procedure:
- Pneumothorax (collapsed lung) during the procedure: rare but possible
- Horner’s syndrome (drooping eyelid, pupil asymmetry, reduced facial sweating on one side): occurs in a small percentage, typically resolves but can be permanent
- Nerve damage beyond the intended sympathetic chain: rare
- Hemothorax (bleeding in chest cavity): rare
- Infection: rare
These are not the primary reasons ETS should be considered carefully. Compensatory sweating is the main reason.
Who Should Consider ETS
ETS is a reasonable consideration for:
- Patients with severe palmar or craniofacial hyperhidrosis who have genuinely failed all other treatments (iontophoresis, Botox, medications)
- Patients who have been fully informed of the compensatory sweating risk and understand what severe compensatory sweating would mean for their quality of life
- Patients who specifically want hands to be dry and accept that trade-offs elsewhere are possible
- Patients consulting with a surgeon who is honest about outcomes and not overselling
It is not appropriate as a first or second-line treatment, and it is not appropriate if the treating physician is not discussing compensatory sweating clearly and at length.
Questions to Ask a Surgeon Before Agreeing to ETS
- What is your personal compensatory sweating incidence in your patients?
- How many of your ETS patients have described their compensatory sweating as worse than their original condition?
- Do you clamp or cut? Why?
- Which nerve level do you plan to treat and what does the evidence say about compensatory risk at that level?
- What is your reversal rate, and how successful have reversals been for compensatory sweating in your experience?
- What non-surgical options am I confident I have exhausted before considering this?
A surgeon who gives you brief or reassuring answers to these questions without engaging seriously is a red flag. An ETS surgeon worth trusting will spend real time on the compensatory sweating conversation, not minimize it.
The Last Resort Standard
There is a reason hyperhidrosis treatment guidelines consistently position ETS as a last resort. It is not because it does not work. It is because its most common serious complication can be worse than the original condition and is not reliably reversible.
For some people with severe hyperhidrosis that has failed everything else, ETS represents a genuine improvement in quality of life. For others, it creates a new problem in exchange for solving the original one. The difficulty is that there is no reliable way to predict in advance which outcome you will have.
Go in with full information. Read the patient communities. Ask the hard questions. And do not consider it until the full treatment ladder has genuinely failed.
→ Hyperhidrosis Treatments: Every Option, Ranked by Effectiveness
→ Iontophoresis for Hyperhidrosis: The Complete Guide
→ Botox for Sweating: How It Works, What It Costs, and Whether It Lasts
Sources
- Endoscopic Thoracic Sympathectomy for Hyperhidrosis: A Systematic Review, PMC, National Library of Medicine
- Hyperhidrosis, StatPearls, National Library of Medicine
- Compensatory Sweating After Sympathectomy: Review of the Literature, PMC, National Library of Medicine
- Hyperhidrosis: Diagnosis and Treatment, American Academy of Dermatology